Nongyu Huang Selected Research

Nongyu Huang Research Topics

Disease

6	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021 - 01/2009
6	Inflammation (Inflammations) 01/2021 - 01/2009
3	Neoplasms (Cancer) 01/2022 - 07/2012
1	Fibrosis (Cirrhosis) 01/2022
1	Carcinogenesis 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Skin Diseases (Skin Disease) 11/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2019
1	Infections 01/2019
1	Communicable Diseases (Infectious Diseases) 05/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2013
1	Colonic Neoplasms (Colon Cancer) 05/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013
1	Carcinoma (Carcinomatosis) 05/2013
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Neoplasm Metastasis (Metastasis) 07/2012
1	Autoimmune Diseases (Autoimmune Disease) 01/2009

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2022 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
2	Imiquimod (Aldara)FDA LinkGeneric 11/2021 - 01/2021
2	Oncostatin MIBA 01/2021 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	Interleukin-22 (IL-22)IBA 01/2021 - 01/2021
2	loricrinIBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 01/2009
2	ErbB Receptors (EGF Receptor)IBA 05/2013 - 07/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	CollagenIBA 01/2022
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	involucrinIBA 01/2021
1	bafilomycin A1IBA 01/2021
1	Cre recombinaseIBA 01/2021
1	AlarminsIBA 01/2021
1	Beclin-1IBA 01/2021
1	WortmanninIBA 01/2021
1	Filaggrin ProteinsIBA 01/2021
1	AcidsIBA 01/2021
1	EpitopesIBA 01/2021
1	AntigensIBA 01/2021
1	Differentiation AntigensIBA 01/2021
1	Calcium-Binding ProteinsIBA 01/2021
1	EnzymesIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	LigandsIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Bovine Serum AlbuminIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	IntegrinsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Caspase 1 (ICE Protease)IBA 01/2021
1	thiazolyl blueIBA 01/2021
1	Mitogen-Activated Protein KinasesIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Recombinases (Recombinase)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Lysosomal-Associated Membrane Protein 1IBA 01/2021
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 01/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2021
1	Interleukin-23 (Interleukin 23)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Type I Secretion SystemsIBA 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	Interleukin-1 (Interleukin 1)IBA 03/2015
1	Keratin-14 (Keratin 14)IBA 02/2014
1	AntioxidantsIBA 05/2013
1	Interleukin-27 (Interleukin 27)IBA 05/2013
1	Immunotoxins (Immunotoxin)IBA 07/2012
1	Gelonium multiflorum GEL proteinIBA 07/2012
1	Single-Chain AntibodiesIBA 07/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2009

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2009
2	Immunotherapy 05/2013 - 01/2009